StudyFinder

A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001

Status: OPEN TO ACCRUAL

I'm interested

Age:

Healthy Volunteers:

Interventions:

drug: Avelumab, drug: Atezolizumab

Conditions:

Colon, Breast, Prostate, Rectum, Other Male Genital, Urinary Bladder, Other Urinary, Kidney

Contact(s): Gwaltney, Lindsey - lbgwaltney@vcu.edu

Principal Investigator: Poklepovic, Andrew, S

Phase: I

IRB Number: HM20023654

System ID: NCT03845166

Back